I do understand the usefulness of info on Diabetes. As someone who write on health, I do know for example that all Indians will have to have a close watch because India will become the Diabetes capital of the world in 2025 with more than 55 percent of the population suffering from type 2 form of the disease.
Also, Diabetes Retinopathy causes blindness to several diabetics and this has been increasing with the numbers of type 2 diabetes cases. However, it's very sad that there aren't much writings on how Type 2 diabetes can affect the VI population. That will be certainly a good info. Subramani -----Original Message----- From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] On Behalf Of Keshav Kumar Sent: Saturday, September 23, 2006 7:42 PM To: K Ramkrishna; [email protected] Subject: Re: [AI] diabetes *********************** No virus was detected in the attachment no filename Your mail has been scanned by InterScan MSS. *********************** I feel that it would be very healthy, if all of us express our views on any controversy, in the same way, as, K Ramkrishna has done here. regards, Keshav. ----- Original Message ----- From: "K Ramkrishna" <[EMAIL PROTECTED]> To: <[email protected]> Sent: Saturday, September 23, 2006 10:03 AM Subject: Re: [AI] diabetes > Dear Bhawani and other members of the list, > > On account of relative physical inaction & inability to go for a swift > walk, > the visually impaired persons have a higher probability of diabetes > attack. > In my opinion any discussion on diabetes is very pertinent to visually > impaired persons in general and to this site in particular. Actually when > I > saw Vijeta's mail, which in my opinion was very informative and > interesting > I was only hoping that one of us should not blow the whistle in the > context > of the topical importance. Before blowing the whistle, we should put the > general interest of the site before our personal interests, tastes & > preferences. e.g. we had an extended & perhaps interminable discussion on > stray dogs and many of us shared our experience on the site on the way > they > were kissed and bit by dogs. While this many not be pertinent to some of > us > on an individual basis, it is of common interest. I request that before > blowing the whistle, which in my opinion should be best left to the > moderator let us ask ourselves whether the topic under discussion is of > common importance pertaining to visually impaired. Some of us raised an > objection when an incident involving an IT professional in Bangalore was > posted. I also feel that we should not recommend any of our members to > post > their messages in any other specific site. I hope this is appreciated. > > Rgds, > > (K. Ramkrishna) > 23.9.06 > ----- Original Message ----- > From: "BHAWANI SHANKAR VERMA" <[EMAIL PROTECTED]> > To: <[email protected]> > Sent: Friday, September 22, 2006 10:40 AM > Subject: Re: [AI] diabetes > > >> please discuss such matter in another group called "say everything". this >> is >> not an appropriate forum for such discussion. thanks. >> >> ----- Original Message ----- >> From: "vijeta" <[EMAIL PROTECTED]> >> To: <[email protected]> >> Sent: Thursday, September 21, 2006 5:22 PM >> Subject: [AI] diabetes >> >> >>> >>> Diabetes >>> >>> Diabetes >>> >>> Diabetes is classified into four catagories with slightly varied >> therapeutic protocols that our customers have seen phenomenal results >> with. >>> >>> Diabetes is a major health concern globally. According to the National >> Daibetes Association, 16 million people in the U.S. have diabetes and >> less >> than 1/2 >>> aren' t even aware that they have it. >>> >>> Diabetes ranks as the number 4 cause death in America with 178,000 >> assocaited deaths annually. 18 - 24,000 people lose their eyesight and >> more >> than 20,000 >>> diabetics are treated for renal disease. Diabetes is the most frequent >> cause of non- traumatic loss of limbs each year. >>> >>> The protocol for Brittle diabetes, Diabetes Insipidus, Diabetes Mellitus >> Type I, Diabetes Mellitus Type II are excellent specific complementary >> therapies. >>> >>> Central to all kits is the DNA insulin product that is homeopathically >> proven to re-teach the pancreas optimal insulin production thereby >> correcting hereditary >>> diabetic predispositions.* DNA insulin contains energetic imprints from >> optimally working pancreatic tissues, non-diabetic DNA and Insulin and >> serves to >>> remind the body of correct pancreatic function. When taken over a period >> of time the body begins to relearn insulin production. DNA Insulin >> manufactured >>> exclusively by PHP labs is truly a breakthrough in Diabetes therapies >>> and >> resonance homeopathy. It is not neccesary to continue taking DNA Insulin >> past >>> a 3 or 6 month adaptation period. We believe in addressing root causes >>> and >> not just supressing symptoms. >>> >>> The kits all also contain PROZN-GL >>> US Patent # 5,834,032(Cyclo his-pro plus Zinc) >>> which showed improvements in biochemical measures of glucose metabolism >>> in >> double-blind studies at UCLA. Cyclo (his-pro) is a naturally occurring >> cyclic >>> dipeptide consisting of histidyl and proline. Concentrations of cyclo >> (his-pro) have been found in the blood, cerebrospinal fluid (CSF), semen, >> brain, >>> spinal cord, and gastrointestinal tract of humans. Studies suggest that >> cyclo (his-pro) is one of numerous compounds in the prostate gland that >> regulate >>> the intestinal absorption of zinc.Both animals and humans with diabetes >> have altered zinc metabolism and zinc is known to play a key role in >> synthesis, >>> storage, and secretion of insulin. Zinc is also required for proper >> glucose utilization by muscle and fat cells. PROZN_GL enhances both zinc >> absorption >>> and glucose utilization, which results in a significant decline in both >> blood and urine glucose levels of diabetic patients.* It appears that >> cyclo >> (his-pro) >>> is an important new agent that can help improve glucose metabolism in >> patients with type diabetes. >>> >>> It is important to monitor your blood sugar and insulin and eat a proper >> diet while on these complementary protocols. These products are not a >> substitute >>> for any pharmaceuticals that your Dr. may have prescribed. >>> Hypoglycemics and Borderline Diabetes >>> >>> >>> Hypoglycemics and Borderline Diabetes: >>> >>> >>> The kit for hypoglycemics and borderline diabetics contains ProZnGL, DNA >> Insulin and Glucogen Complex >>> >>> ProZn GL US Patent # 5,834,032. PROZN_GL enhances both zinc absorption >> and glucose utilization, which results in a significant decline in both >> blood and >>> urine glucose levels of diabetic patients.* >>> >>> C19 DNA - Aids in correcting hereditary diabetes by re-teaching the body >> insulin production >>> >>> SGC Glucogen Complex 120 capsules. Is a metabolic product that helps to >> regulate sugar levels and insulin. >>> >>> Dr. vijeta >>> To unsubscribe send a message to [EMAIL PROTECTED] >> with the subject unsubscribe. >>> >>> To change your subscription to digest mode or make any other changes, >> please visit the list home page at >>> >> http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.i n >>> >> >> >> DISCLAIMER: >> The Information transmitted in this email is solely for the addressee. It >> is confidential and may be legally privileged. Access to this email by >> anyone else is unauthorized. Any disclosure, copying, distribution or any >> action taken by anyone other than by the intended recipient is prohibited >> and may be unlawful. If you are not the intended recipient then kindly >> delete the mail from your system. Any opinion or views expressed in this >> mail may not necessarily reflect that of Punjab National Bank. The bank >> considers unencrypted email as an insecure mode of communication. >> >> To unsubscribe send a message to [EMAIL PROTECTED] >> with the subject unsubscribe. >> >> To change your subscription to digest mode or make any other changes, >> please visit the list home page at >> >> http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.i n >> > > > ------------------------------------------------------------------------ --------------------------------------------- > This e-mail contains privileged information or information belonging to > IDBI Ltd. and is intended solely for the addressee/s. Access to this > email by anyone else is unauthorized. Any copying (whole or partial) or > further distribution beyond the original recipient is not intended, and > may be unlawful. The recipient acknowledges that IDBI Ltd. is unable to > exercise control or ensure or guarantee the integrity of the contents of > the information contained in e-mail transmissions and further > acknowledges that any views expressed in this message are those of the > individual sender and are not binding on IDBI Ltd. E-mails are > susceptible to alteration and their integrity cannot be guaranteed. IDBI > Ltd. does not accept any liability for damages caused on account of this > e-mail. If you have received this email in error, please contact the > sender and delete the material from your computer. > ------------------------------------------------------------------------ --------------------------------------------- > > > To unsubscribe send a message to [EMAIL PROTECTED] > with the subject unsubscribe. > > To change your subscription to digest mode or make any other changes, > please visit the list home page at > http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.i n To unsubscribe send a message to [EMAIL PROTECTED] with the subject unsubscribe. To change your subscription to digest mode or make any other changes, please visit the list home page at http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.i n To unsubscribe send a message to [EMAIL PROTECTED] with the subject unsubscribe. To change your subscription to digest mode or make any other changes, please visit the list home page at http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.in
